Past Site Visits and Events
 |
|
| New England Biolabs (NEB) site visit, 240 County Rd, Ipswich, MA 01938 | |
| Event time/date: 9:45 AM - 12:00 PM, Friday, Apr 5th, 2024 | |
|
Hello Graduate Students and Post Docs! Are you considering a path in biotech? Industry Exploration Program (IndEx) is excited to announce site visit to New England Biolabs(NEB). This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. Founded in the mid 1970s, New England Biolabs has been a world leader in the discovery and production of enzymes for molecular biology applications. Please see the attached document to learn more about history of New England Biolabs and the Ipswich campus. |
|
 |
|
 |
|
| Exponent Career Event, Faculty Conference Room (S1-342), UMass Chan Medical School | |
| Event time/date: 10:45 AM - 1 PM, Friday, Feb 16th, 2024 | |
|
IndEx is excited to kick off the New Year by hosting a career event with Exponent, an engineering and scientific consulting firm that specializes in more than 90 technical disciplines.
Have you considered a career as a scientific consultant? Are you interested in learning more about the life of a scientific consultant? If so, come join us at 10:45 am, on Feb 16th, 2024, in the Faculty Conference Room (S1-342) located in the Medical School building for an insightful career event with Exponent.
We encourage you to check out Exponent's company website and explore their current career openings.
|
|
 |
|
 |
|
| Tessera Therapeutics Site Visit, 100 Research Drive, Worcester, MA | |
|
Event time/date: 9:00 AM – 1:00 PM, Tuesday, May 9, 2023 Are you considering a path in biotech? Industry Exploration Program (IndEx) is excited to announce a site visit to Tessera Therapeutics. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. Tessera Therapeutics is a Flagship Pioneering company founded in 2018 focused on developing genetic medicines. They are pioneering a new category of genome editing technology based upon the rich molecular biology of Mobile Genetic Elements (MGEs). For more information, please visit the Tessera Therapeutics.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
 |
|
| AbbVie Site Visit, 100 Research Drive, Worcester, MA | |
|
Event time/date: 8:30 AM – 1:00 PM, Monday, May 8, 2023 Founded in 2012, AbbVie is a pharmaceutical company now ranked 6th on the list of largest biomedical companies by revenue (via Wikipedia). Their areas of focus include immunology, oncology, neuroscience, eye care, aesthetics and beyond. For more information, please visit AbbVie.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
 |
|
| Vertex Pharmaceuticals Site Visit, 50 Northern Ave, Boston, MA | |
|
Event time/date: 1:00 PM – 3:00 PM, Monday, April 24, 2023 Are you considering a path in biotech? Industry Exploration Program (IndEx) is excited to announce a site visit to Vertex Pharmaceuticals. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. For more information, please visit Vertex Pharmaceuticals. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
| ROME Therapeutics, 201 Brookline Ave. Suite 1001, Boston, MA | |
|
Event time/date: 2:00 PM – 4:00 PM, Wednesday, April 5, 2023 Are you considering a path in biotech? Industry Exploration Program (IndEx) is excited to announce a site visit to ROME Therapeutics. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. Launched in 2020, ROME Therapeutics is a biotech company based in Boston that focuses on developing novel therapies for cancer and autoimmune diseases by illuminating the role of the dark genome in human health and disease. In 2021 they were named one of C&EN’s “10 Start-Ups to Watch”. For more information, please visit the ROME Therapeutic.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Alnylam Open House, 675 West Kendall St., Cambridge, MA |
|
|
Event time/date: 8:30 AM – 1:00 PM, Monday, April 3, 2023 Are you considering a path in biotech? The Industry Exploration Program (IndEx) is excited to announce an open house to Alnylam Pharmaceuticals. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. For more information, please visit Alnylam Pharmaceuticals. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Atalanta Therapeutics Site Visit, 51 Sleeper Street, 7th Floor, Boston, MA |
|
|
Event time/date: 10:00 AM – After lunch, Thursday, November 3, 2022 The Industry Exploration Program (IndEx) at UMass Chan Medical School is excited to announce our upcoming event. Are you thinking about your next step and considering a path in biotech? Join us for a meeting with scientists from Atalanta Therapeutics! About Atalanta Therapeutics: Started out of UMass Chan Medical School in 2019, Atalanta Therapeutics is a biotech company based in Boston’s Seaport that specializes in the development of therapeutic siRNAs for the treatment of neurodegenerative diseases such as Huntington’s Disease and Alzheimer’s. In 2021 they received $110 million in Series A funding from F-Prime Capital. Presenters:
They will share their career paths in industry, what working in industry is like, as well as tips and resources for landing a job in industry. Information about job opportunities will be shared as well. For more information, please visit Atalanta Therapeutics. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
 |
|
| C4 Therapeutics Virtual Visit | |
|
Event time/date: 4:00 PM – 4:00 PM, Wednesday, October 30, 2019 Are you thinking about your next career step and considering a career path in Biotech? Join us for a virtual meeting with scientists from C4 Therapeutics, a Boston-based biotech company. Presenters:
They will share their career paths in the industry as well as tips and resources for landing a job in the industry. Information about internships and job opportunities at C4 Therapeutics will be shared as well. About C4 Therapeutics: For more information, please visit C4 Therapeutic. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
AbbVie Bioresearch Center Site Visit, 100 Research Drive, Worcester, MA |
|
|
Event time/date: 9:00 AM – 1:00 PM, Monday, September 9, 2019 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to AbbVie’s campus in Worcester, MA. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. With nearly 30,000 employees including scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe, AbbVie is coming up with new approaches to address today’s health issues—from life-threatening illnesses to chronic conditions. They are targeting specific difficult-to-cure diseases with their core R&D expertise to advance science. For more information, please visit AbbVie. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Intellia Therapeutics Site Visit, Cambridge MA |
|
|
Event time/Date: 10:00 AM – 1:45 PM, Thursday, May 16, 2019
The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to Intellia Therapeutics’s campus in Cambridge, MA. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. Intellia Therapeutics is revolutionizing medicine by harnessing the power of genome editing to develop potential cures. They are focused on bringing hope to people living with conditions including cancer, genetic disorders, viral infections, inflammatory disorders and many more. For more information, please visit Intellia Therapeutics.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Sanofi-Genzyme |
|
|
Event time/date: 1:00 - 4:30 PM, Monday, March 11, 2019 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to Sanofi Genzyme’s campus in Framingham, MA. This is a great opportunity to expand your network and learn more about industry careers, both at and beyond the bench. Founded in Boston in 1981, Genzyme rapidly grew and became recognized for its pioneering development of treatments for rare genetic disorders and innovative contributions to medical science and biomanufacturing. In 2011, Genzyme became part of Sanofi, a French multinational life science company, and became one of the world’s largest biotechnology companies. Sanofi Genzyme engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but also develops over-the-counter medications. The company’s research covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, immunology, oncology, rare diseases, infectious diseases and vaccines (Sanofi is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur). For more information, please visit Sanofi-Genzyme.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
CRISPR Therapeutics |
|
|
Event time/date: 11:00 AM - 3:00 PM, Wednesday, December 12, 2018 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to CRISPR Therapeutics' campus in Cambridge, MA on Wednesday, December 12th, 11:00 – 3:00 PM! Their multi-disciplinary team of world-class researchers and drug developers work every day to translate their CRISPR/Cas9 technology into breakthrough human therapeutics. CRISPR Therapeutics' lead program targeting the blood diseases β-thalassemia and sickle cell disease has entered clinical testing, and their immuno-oncology programs focused on CRISPR/Cas9-edited allogeneic CAR-T cell therapies, have the potential to deliver a new generation of cancer therapies to patients. This is a great opportunity to expand your network and learn more about industry careers. For more information, please visit CRISPR Therapeutics.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
MassBiologics |
|
|
Event time/date: 12:00 - 3:00 PM, Friday, August 10, 2018 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to MassBiologics' campus in Boston, MA on Friday, August 10th from 12:00 - 3:00 PM! MassBiologics is the only non-profit, FDA-licensed manufacturer of vaccines in the United States. For over 100 years, MassBiologics has worked to improve public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and most recently, monoclonal antibodies. MassBiologics currently manufactures Tetanus and Diphtheria Toxoids, the Adsorbed (Td) vaccine and distributes it nationwide. This is a great opportunity to expand your network and learn more about industry careers. For more information, visit MassBiologics.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Voyager Therapeutics |
|
|
Event time/date: 1:00 PM - 4:30 PM, June 8, 2018 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to Voyager Therapeutics' campus in Cambridge, MA on Friday, June 8th, 1:00 - 4:30 PM! Voyager Therapeutics develops gene therapies from discovery, preclinical and clinical development, through to commercialization. They focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of advanced Parkinson’s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Huntington’s disease, Friedreich’s ataxia, neurodegenerative diseases related to defective or excess aggregation of tau protein in the brain including Alzheimer’s disease, and severe, chronic pain. They innovate and invest in novel adeno-associated virus (AAV) vector engineering and optimization, manufacturing that includes a baculovirus production system for producing AAV vectors at scale in insect-derived cells, and dosing that includes intraparenchymal, intrathecal and intravenous delivery techniques. For more information, visit Voyager Therapeutics.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
KSQ Therapeutics |
|
|
Event time/date: 1:00 PM - 3:00 PM March 20, 2018 The Industry Exploration Program (IndEx) at UMass Chan is excited to announce another industry site visit to KSQ Therapeutics's campus in Cambridge, MA on Tuesday, March 20th, 1:00-3:00 PM! KSQ Therapeutics's broad expertise in their proprietary CRISPRomics™ drug discovery engine, has elucidated the function that each human gene plays in multiple diseases, providing a unique and more comprehensive understanding of disease biology. The quality of these insights enables their scientists to rapidly identify and validate high-confidence, patient-tailored, novel drug targets and then focus their collective efforts on the development of medicines with the greatest potential to impact the lives of patients. KSQ has initiated a pipeline of preclinical discovery programs and was founded in 2015. This is a great opportunity to expand your network and learn more about industry careers. For more information, visit KSQ Therapeutics.
----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
GE Healthcare Life Sciences |
|
|
Event time/date: 1:30 PM - 4:00 PM, May 12, 2017 Come visit GE Healthcare Life Sciences' brand new campus located in Marlborough, Massachusetts. GE’s broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help their customers to deliver better care to more people around the world at a lower cost. In addition, they partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. This is a great opportunity to expand your network and learn more about industry careers. For more information, visit GE Healthcare Life Sciences.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Ginkgo BioWorks |
|
|
Event time/date: 1:00 PM - 4:00 PM, December 19, 2016 Ginkgo BioWorks located in Boston, Massachusetts, is a biotechnology company focused on designing custom microbes for a variety of industrial settings. By focusing on the production of cultured ingredients, including yeasts and enzymes for a variety of manufacturing applications, as well as improving current fermentation and engineering technologies, Ginkgo BioWorks hopes to expand the link between biology and technology. For more information, visit GinkgoBioWorks.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
QIAGEN |
|
|
Event time/date: 1:00 PM - 4:00 PM, December 7, 2016 QIAGEN, an international company with headquarters in Germany, provides services to over half a million customers worldwide, through 35 offices in 25 countries. QIAGEN’s slogan of “Sample to Insight” highlights its commitment to providing researchers with the tools and technologies to efficiently and reliably analyze samples and address scientific inquiries, whether at the laboratory bench or the hospital bedside. QIAGEN’s focus on innovative solutions and understanding of research challenges provides researchers with the tools and opportunities to address a broad spectrum of scientific questions. For more information, visit QIAGEN. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Alnylam Pharmaceuticals |
|
|
Event time/date: 10:00 AM - 2:00 PM, November 11, 2016 Alnylam Pharmaceuticals, located in Cambridge MA, is a leading pharmaceutical company developing RNAi therapeutics for disease treatment. Ranked in 2015 as one of the top places to work by the Boston Globe, its exciting therapeutic pipelines in hepatic, cardio-metabolic and genetic medicine represent the transition of RNAi from bench top tool to innovative treatment. For more information, visit Alnylam Pharmaceuticals.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
BERG Health Site Visit |
|
|
Event time/date: 1:00 PM - 4:00 PM, September 19, 2016 BERG, in Framingham, MA, is a biopharma company with a unique approach to therapeutic discovery and pipelines in oncology, endocrinology and neurology. Utilizing an AI-based Interrogative Biology® platform and with a focus on precision medicine, BERG Health's developmental program centers around the patient, using the patient's own biology to drive research forward, with the hope of developing faster clinical diagnoses and safer therapeutic options to be implemented worldwide. For more information visit BERG Health. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Broad Institute Site Visit |
|
|
Event time/date: 1:00 PM - 4:00 PM, June 17, 2016 The Eli and Edythe L. Broad Institute of Harvard and MIT, located in Cambridge, MA, is a collaborative effort combining a diverse group of bio-scientific professionals across partner institutions to address current challenges in translational medicine and the expansion of our understanding and treatment of disease. Based on large-scale collaborations of the past at Harvard and MIT, the Broad Institute currently links research done at MIT, Harvard and Harvard's affiliated major teaching hospitals in the Boston area, creating a local community of over 150 faculty and over 1500 scientists, with international connections to over 100 research projects across more than 40 countries. The Broad Institute presented a unique opportunity for our trainees to explore working at the intersection of educational research and translational science. For more information visit Broad Institute. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
Careers for PhDs: A Career Discussion with John Finch, JD, SPHR (On Site Event) |
|
|
Visit time/date: 10:00 AM - 12:00 PM, June 9, 2016 IndEx invited John Finch, JD, SPHR, currently the Deputy Director, Administration and Finance at MassBiologics to visit campus and present on his approach to career development and interview skill development. Mr. Finch is an entrepreneurial administrative leader with 30 years of experience in a variety of disciplines, environments and industries, who has been with MassBiologics since 2003, where he took the lead in building its current administrative and operational infrastructure. For more information on MassBiologics or Mr. Finch, see MassBiologics or MassBiologics Management.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
MassBiologics Site Visit |
|
|
Event time/date: 11:30 AM - 2:30 PM, April 7, 2016 MassBiologics, located in Boston (Mattapan, MA), is the only non-profit, FDA-licensed manufacturer of vaccines in the United States. For over 100 years, MassBiologics has worked to improve public health through applied research, development and production of biological products. For more information visit MassBiologics. -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
Careers for PhDs: Industry Roles Beyond the Bench (On-Site Event) |
|
|
Visit time/date: 3:00 PM - 5:00 PM on December 10, 2015 Presented in conjunction with the Center for Biomedical Career Development (cBCD), IndEx hosted 4 industry professionals (of which 3 were UMass Chan alumni) on campus for a panel discussion on non-bench industry careers. This presented a unique opportunity where students and postdocs got to interact with professionals not usually available for site visits. Highlighted careers were: patent lawyer, regulatory medical writer, staff applications scientist and medical science liaison. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
New England BioLabs (NEB) |
|
|
Visit time/date: 12:00 PM - 3:30 PM, May 22, 2015 New England BioLabs (NEB), recognized worldwide as a leader in recombinant and native enzyme development and production, is a privately owned international company with headquarters located in Ipswich, MA. Leaders in restriction enzyme development for almost 40 years, NEB has more recently expanded their catalogue to other research fields, such as RNA and epigenetic analysis. With a focus on supporting the scientific community with superior tools for genomic research as well as an expansive in-house research effort, NEB offers a wide variety of career opportunities. For more information, visit New England BioLabs. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Novartis/NIBR |
|
|
Visit time/date: 9:30 AM - 11:45 AM, March 30th, 2015 For more information, visit Novartis and NIBR. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Bluebird Bio |
|
|
Visit time/date: 11 AM - 4:30 PM on October 21, 2014 Bluebird Bio, located in Cambridge, MA, is a company focusing on using gene therapy in the treatment of severe genetic and orphan diseases such as beta-thalassemia, sickle cell disease, and various types of cancer. With two clinical stage products, a gene therapy platform widely applicable to a number of diseases, and a focus on providing hope to patients, Bluebird Bio hopes to shift the focus of treatment of these diseases to addressing their underlying causes, rather than through alleviation of symptoms. For more information, visit Bluebird Bio. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
MassBiologics |
|
|
Visit time/date: 10 AM - 3:30 PM, May 16th, 2014 MassBiologics, located in Boston, is the only non-profit, FDA-licensed manufacturer of vaccines in the United States. For over 100 years, MassBiologics has worked to improve public health through applied research, development and production of biological products. For more information visit MassBiologics. -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Genzyme |
|
|
Visit time/date: 1:00-3:30 PM, May 2, 2014 Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. For more information visit Genzyme. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Massachusetts Biomedical Initiatives (MBI) |
|
|
Visit time/date: 1:00 PM - 3:30 PM, October 31, 2013 Massachusetts Biomedical Initiatives (MBI) is a private, independent economic development organization dedicated to job creation and innovative healthcare throughout Massachusetts by promoting the growth of start-up biomedical companies. MBI offers support to creative entrepreneurs with sound scientific business plans. Through its MBI Incubator facilities located in Worcester, MBI lowers barriers to success for emerging companies by providing cost-effective, high-quality laboratory space and support services. MBI is committed to collaborating with the academic, business and government communities to promote Massachusetts as the world leader in the life science industry. For more information visit Massachusetts Biomedical Initiatives. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
Athena |
|
|
Visit time/date: 11:30 AM - 3:00 PM, April 5, 2013 Athena Diagnostics is a leader in diagnostic testing for neurological diseases and offers innovative tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. Athena, a division of Quest Diagnostics, is dedicated to providing neurologists and other physicians and specialists with insights that can improve patient health. Athena provides the most comprehensive test menu and intellectual property portfolio for neurological, endocrine, and renal conditions through more than 350 diagnostic tests. For more information visit Athena. -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|
|
|
|
|
AbbVie (formerly Abbott) |
|
|
Visit time/date: 9:00 AM - 12:30 PM, April 12, 2013 Research and innovation are the cornerstones of AbbVie's business as a global biopharmaceutical company. Our research and innovation focus on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver economic value, particularly where there is a significant need around the world in certain disease areas. These areas include hepatitis C, neuroscience, immunology, oncology, chronic kidney disease, and women's health. For more information visit AbbVie. ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
